Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals

Peptide receptor radionuclide therapy (PRRT) using Lutetium-177 (<sup>177</sup>Lu) based radiopharmaceuticals has emerged as a therapeutic area in the field of nuclear medicine and oncology, allowing for personalized medicine. Since the first market authorization in 2018 of [¹⁷⁷Lu]Lu-DOT...

Full description

Saved in:
Bibliographic Details
Main Authors: Typhanie Ladrière (Author), Julie Faudemer (Author), Elise Levigoureux (Author), Damien Peyronnet (Author), Cédric Desmonts (Author), Jonathan Vigne (Author)
Format: Book
Published: MDPI AG, 2023-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available